ABSTRACT
Introduction Mental disorders are increasingly conceptualized as overlapping spectra with underlying polygenicity, neurodevelopmental etiology, and clinical comorbidity. They share multi-level neurobiological alterations, including network-like brain structural alterations. However, whether alteration patterns covary across mental disorders in a biologically meaningful way is currently unknown.
Methods We accessed summary statistics on cortical thickness alterations from 12,024 patients with six mental disorders and 18,969 controls from the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. First, we studied cortical thickness co-alteration networks as a form of pathological structural covariance. We identified regions exhibiting high inter-regional covariance across disorders (‘hubs’), and regions that strongly connect to these hubs facilitating network spreading of disease effects (‘epicenters’). Next, we applied manifold learning to reveal organizational gradients guiding transdiagnostic patterns of illness effects. Last, we tested whether these gradients capture differential cortical susceptibility with respect to normative cortical thickness covariance, cytoarchitectonic, transcriptomic, and meta-analytical task-based profiles.
Results Co-alteration network hubs were linked to normative connectome hubs and anchored to prefrontal and temporal disease epicenters. The principal gradient derived from manifold learning captured maximally different embedding of prefrontal and temporal epicenters within co-alteration networks, followed a normative cortical thickness gradient, and established a transcriptomic link to cortico-cerebello-thalamic circuits. Moreover, gradients segregated functional networks involved in basic sensory, attentional/perceptual, and domain-general cognitive processes, and distinguished between regional cytoarchitectonic profiles.
Conclusion Together, our findings indicate that disease impact occurs in a synchronized fashion and along multiple levels of hierarchical cortical organization. Such axes can help to disentangle the different neurobiological pathways underlying mental illness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MDH was funded by the German Federal Ministry of Education and Research (BMBF) and the Max Planck Society. SL acknowledges funding from Fonds de la Recherche du Quebec, Sant (FRQ S) and the Canadian Institutes of Health Research (CIHR). BYP was funded by the National Research Foundation of Korea (NRF 2021R1F1A1052303), Institute for Information and Communications Technology Planning and Evaluation (IITP) funded by the Korea Government (MSIT) (2020 0 01389, Artificial Intelligence Convergence Research Center, Inha University; 2021 0 02068, Artificial Intelligence Innovation Hub), and Institute for Basic Science (IBS R015 D1). MH is supported by a personal Veni grant from the Netherlands Organization for Scientific Research (NWO, grant number 91619115). BB acknowledges research funding from the SickKids Foundation (NI17 039), the Natural Sciences and Engineering Research Council of Canada (NSERC; Discovery 1304413), CIHR (FDN 154298, PJT 174995), the Azrieli Center for Autism Research (ACAR), an MNI-Cambridge collaboration grant, salary support from FRQ-S (Chercheur-Boursier), BrainCanada, the Helmholtz BigBrain Analytics and Learning Lab (Hiball) and the Canada Research Chairs (CRC) Program. SLV was supported by the Max Planck Society through the Otto Hahn Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data analyzed in this manuscript were obtained from open-access sources. Disorder-specific Cohen's d maps derived from ENIGMA meta-analyses were accessed via the ENIGMA Toolbox (https://enigma-toolbox.readthedocs.io/en/latest/). Through the toolbox, we also accessed normative connectivity data from a Human Connectome Project young adult sample (HCP; http://www.humanconnectome.org/), the von Economo-Koskinas cytoarchitectonic atlas, and gene transcriptomic data from the Allen human brain atlas (https://human.brain-map.org/). Further genetic analyses were performed using the cell-specific enrichment analysis tool (http://genetics.wustl.edu/jdlab/csea-tool-2/). The functional meta-analysis was based on the NeuroSynth database (https://neurosynth.org/). Gradient mapping analyses were based on open-access tools (BrainSpace, https://brainspace.readthedocs.io/en/latest/). Visualizations were carried out using BrainStat (https://github.com/MICA-MNI/BrainStat) in combination with ColorBrewer (https://github.com/scottclowe/cbrewer2).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced will be made available online at https://github.com/CNG-LAB/cngopen/transdiagnostic_gradients